University of Picardie Jules Verne
Also known as: Amiens (FR), University College Hospital | Amiens University | Amiens University Hospital | Centre Hospitalier Universiatire Amiens | Centre Hospitalier Universitaire, Amiens | chu amiens | CHU amiens | CHU Amiens | CHU AMIENS | CHU Amiens France | CHU Amiens, France | CHU AMIENS NORD - AMIENS | CHU Amiens Picardie | CHU Amiens-Picardie | CHU Amiens sud 80004 Amiens | CHU sud AMIENS France | University Hopsital of Amiens | University of Amiens
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2004Last known activity
Nov 5, 2025
Timeline
1960s
- Jun 1, 1969
University of Picardie Jules Verne— Founded
Drugs by trial phase (94 distinct, 84 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (47 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (14 own, 0 via acquisition)
Indications
Studied for
- Acalculous Cholecystitis
- Acute Kidney Injury
- Acute Lung Injury
- Agnosia
- Alcoholism
- Amenorrhea
- Anemia
- Arteriovenous Malformations
- Arteritis
- Biliary Fistula
- Botulism
- Breech Presentation
- Brugada Syndrome
- Candidiasis
- Cholecystitis
- Chondrocalcinosis
- Cognition Disorders
- Communicable Diseases
- Complex Regional Pain Syndromes
- Congenital Abnormalities
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Dyskinesias
- Fibrosis
- Fistula
- Giant Cell Arteritis
- Glioblastoma
- Head and Neck Neoplasms
- Hemangioma
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hyperoxia
- Infections
- Intestinal Obstruction
- Intraabdominal Infections
- Kidney Failure, Chronic
- Leg Ulcer
- Leukemia
- Leukemia, Plasma Cell
- Liver Cirrhosis
- Liver Diseases
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Mastocytosis
- Mastocytosis, Systemic
- Medulloblastoma
- Multiple Myeloma
- Muscular Dystrophies
- Muscular Dystrophy, Oculopharyngeal
- Mycobacterium avium-intracellulare Infection
- Mycobacterium Infections
- Mycobacterium Infections, Nontuberculous
- Neoplasms, Plasma Cell
- Obesity, Morbid
- Parkinson Disease
- Polycystic Ovary Syndrome
- Polymyalgia Rheumatica
- Precancerous Conditions
- Premature Birth
- Prolapse
- Psoriasis
- Recurrence
- Reflex Sympathetic Dystrophy
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Shock
- Shock, Septic
- Somatoform Disorders
- Syndrome
- Tachycardia
- Tachycardia, Supraventricular
- Tachycardia, Ventricular
- Tardive Dyskinesia
- Ulcer
- Varicose Ulcer
- Vasoplegia
Recent trials (50)
- NCT07030803Lead sponsorN/ANov 5, 2025
- NCT07077772Sponsor investigatorN/AOct 31, 2025
- NCT07077772Lead sponsorN/AOct 31, 2025
- NCT07037043Lead sponsorPhase 3Aug 31, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06865040Lead sponsorN/AMar 4, 2025
- NCT06731647Lead sponsorPhase 2Nov 12, 2024
- NCT06585020Lead sponsorPhase 2Oct 31, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06381063Lead sponsorN/AMar 27, 2024
- NCT05699005CollaboratorPhase 1Feb 28, 2023
- NCT05368753Lead sponsorPhase 4Mar 9, 2022
- NCT05276596Lead sponsorN/AMar 3, 2022
- NCT05762172Lead sponsorN/AFeb 1, 2022
- NCT05153837Lead sponsorN/ANov 30, 2021
Details
- Founded
- Amiens, FR Jun 1, 1969
- Last known activity
- Nov 5, 2025